Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Butland, Mary Field-Smith, John Ramsey, H. Anderson (2013)
Twenty-five years of volatile substance abuse mortality: a national mortality surveillance programme.Addiction, 108 2
H. Ghodse, K. Ahmed, J. Corkery, Vinesha Naidoo, F. Schifano (2012)
Trends in UK deaths associated with abuse of volatile substances, 1971-2009
S. Maclean, Jacqui Cameron, Angela Harney, N. Lee (2012)
Psychosocial therapeutic interventions for volatile substance use: a systematic review.Addiction, 107 2
S. Maclean (2005)
“It Might Be a Scummy-Arsed Drug but it's a Sick Buzz”: Chroming and PleasureContemporary Drug Problems, 32
S. Maclean, P. d'Abbs (2006)
Will modifying inhalants reduce volatile substance misuse? A reviewDrugs: Education, Prevention and Policy, 13
P. Brand, Solina Li, Martin White (2017)
Young People’s Statistics from the National Drug Treatment Monitoring System (NDTMS): 1 April 2016 to 31 March 2017
J. Nguyễn, C. O'Brien, Salena Schapp (2016)
Adolescent inhalant use prevention, assessment, and treatment: A literature synthesis.The International journal on drug policy, 31
S. Maclean (2008)
Volatile bodies: stories of corporeal pleasure and damage in marginalised young people's drug use.The International journal on drug policy, 19 5
PurposeThe purpose of this paper is to provide a commentary on new information from the Office for National Statistics (ONS) on deaths caused by volatile substance abuse (VSA) in Great Britain which occurred between 2001 and 2016.Design/methodology/approachComparing the new study with previous mortality data, the authors consider the strengths and some limitations of the analysis provided by ONS.FindingsBy utilising a broader range of codes and collating additional information from death certificates, the new report provides a more comprehensive measure of VSA mortality than was previously available, showing increasing prevalence of deaths. The age profile of people dying is older than in previous studies. Most deaths were associated with inhalation of gases and almost three-quarters of deaths involved volatile substances alone.Practical implicationsUnderstanding VSA mortality is essential for service planning. It is important that we identify why so many people whose deaths are associated with VSA are not accessing treatment, with particular concern about treatment access for those who only use volatiles. Training to support drug and alcohol and other health service staff to respond to VSA is essential. In future reports, data to identify socioeconomic correlations of VSA deaths would enable targeted responses. Additionally, information on whether deaths occur in long term rather than episodic or one-off users could enable risk reduction education.Originality/valueThis paper shows how data on VSA deaths may inform for policy and service planning.
Drugs and Alcohol Today – Emerald Publishing
Published: Jun 3, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.